日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of CD245 as myosin 18A, a receptor for surfactant A: A novel pathway for activating human NK lymphocytes

鉴定 CD245 为肌球蛋白 18A,一种表面活性剂 A 的受体:一种激活人类 NK 淋巴细胞的新途径

A De Masson, J Giustiniani, A Marie-Cardine, J D Bouaziz, N Dulphy, D Gossot, P Validire, A Tazi, C Garbar, M Bagot, Y Merrouche, A Bensussan

Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients

转移性肾细胞癌患者适合接受细胞因子免疫治疗。一项纳入181例患者的单中心研究分析

Philip, T; Negrier, S; Lasset, C; Coronel, B; Bret, M; Blay, J Y; Merrouche, Y; Carrie, C; Kaemmerlen, P; Chauvin, F